February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|2014 HIV/Hepatitis C Coinfection Update|
|Zero HIV Infections Seen Through Condomless Sex When HIV-Positive Partner Is on Effective Treatment|
|CROI 2014 Preview: Hot Topics in HIV and Hepatitis Research|
|Exploring Factors Linked to Longer Survival Among ART Users|
|Coverage of CROI 2014: The 21st Conference on Retroviruses and Opportunistic Infections|
|Update on Mississippi Child Cured of HIV, Plus Second Child Shows Signs of HIV Remission|